Drug for treating chronic gastritis

Abstract

The invention relates to a drug for treating chronic gastritis. The drug comprises the following traditional Chinese medicines in parts by weight: 5-10 parts of fructus amomi, 10-15 parts of rhizoma cyperi, 8-16 parts of pericarpium arecae, 6-12 parts of elecampane, 10-15 parts of radix curcumae, 20-25 parts of radix paeoniae alba, 3-12 parts of gizzard pepsin, 2-8 parts of dandelion, 12-20 parts of radix bupleuri, 4-14 parts of rhizoma zingiberis, 6-16 parts of cassia twig, 15-20 parts of citrus chirocarpus, 8-12 parts of ligusticum wallichii, 25-30 parts of liquorice, 8-16 parts of malt, 15-30 parts of Chinese-date, 3-12 parts of radix scrophulariae, 5-10 parts of pseudo-ginseng, 3-9 parts of holly bark, 6-12 parts of bletilla striata, 4-14 parts of polygonum chinense, 3-8 parts of hairy euphorbia, 8-12 parts of cuttlebone, and 3-12 parts of fritillaria thunbergii. The drug treats both symptoms and root causes from an overall human body after being eaten, and has the effects of tonifying spleen and whetting the appetite, relieving emergency and stopping pain, astringing to stop bleeding, and evacuating and bringing down a fever. The drug is significant in treatment effect in the aspect of treatment of the chronic gastritis, and high in recovery rate; the effective rate is 95.56 percent.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating chronic gastritis. Background technique [0002] Chronic gastritis refers to various chronic gastric mucosal inflammatory lesions caused by different etiologies. It is a common disease, and its incidence rate ranks first among various stomach diseases. Chronic gastritis often has a certain degree of atrophy (loss of function of the mucosa) and metaplasia, often involving the cardia with loss of G cells and decreased secretion of gastrin, and can also involve the body of the stomach with loss of the oxyntic glands, resulting in gastric acid, Reduction of pepsin and endogenous factors. [0003] The clinical manifestations of chronic gastritis are mainly loss of appetite, upper abdominal discomfort or dull pain, belching, acid regurgitation, nausea, vomiting, etc., which are persistent or recurrent. Body gastritis and antral gastritis can have di...

AI Technical Summary

Problems solved by technology

[0004] At present, the treatment of chronic gastritis is mainly based on western medicine. Long-term use of western medicine not only produces side effects, but al...